cellvie is pioneering Therapeutic Mitochondria Transfer, a novel treatment approach aimed at the cellular energy metabolism. The technology's first application will be in ischemia-reperfusion injury, specifically in kidney transplantation. But the aim is to develop a broad platform.

Products, services, technology

cellvie is pioneering Therapeutic Mitochondria Transfer. The modality being used are mitochondria, the powerhouses of the cell. They are prepared and delivered using proprietary methods and systems, in order to re-invigorate the cell energy metabolism - e.g. in ischemia-distressed cells.

Cooperation possibilities

cellvie is open to collaborations in the field of Therapeutic Mitochondria Transfer. These may include partnerships for development as well as licensing deals.

Location

Lauchefeld 31, 9548 Matzingen

Facts & figures
  • Type of organization

    Private company

  • Year of foundation

    2020

  • Number of employees in Switzerland

    1-9

Key business